Bedeutung zellulärer Anheftungsfaktoren für die Filovirus-Infektion |
|
Clinical Chemistry of Patients With Ebola in Monrovia, Liberia |
|
Complete genome sequences of three ebola virus isolates from the 2014 outbreak in west Africa |
|
Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection |
|
Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain |
|
Development of a multiplex microsphere immunoassay for the detection of antibodies against highly pathogenic viruses in human and animal serum samples |
|
Development of an Immunochromatography Assay (QuickNavi-Ebola) to Detect Multiple Species of Ebolaviruses |
|
Discovery of an antibody for pan-ebolavirus therapy |
|
Distinct transcriptional responses to fatal Ebola virus infection in cynomolgus and rhesus macaques suggest species-specific immune responses |
|
Ebola Laboratory Response at the Eternal Love Winning Africa Campus, Monrovia, Liberia, 2014-2015 |
|
Ebola: Lessons on Vaccine Development |
|
Ebola vaccine trials: progress in vaccine safety and immunogenicity |
|
EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain |
|
Ebola virus does not block apoptotic signaling pathways. |
|
Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis |
|
The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherin |
|
The Ebola virus glycoprotein and its immune responses across multiple vaccine platforms |
|
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo |
|
Ebola Virus Infection in Commonly Used Laboratory Mouse Strains |
|
Ebola virus – prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine |
|
Ebola virus vaccines: an overview of current approaches |
|
Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages |
|
Efficacy of Vesicular Stomatitis Virus-Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona |
|
Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies |
|
Évaluation fonctionnelle de l'entrée des cellules et de l'utilisation des récepteurs pour les β-coronavirus de la lignée B, y compris le 2019-nCoV |
|
Evaluation of Ebola Virus Countermeasures in Guinea Pigs. |
|
Favipiravir (T-705) Protects IFNAR−/− Mice against Lethal Zika Virus Infection in a Sex-Dependent Manner |
|
Fcγ-receptor IIa-mediated Src Signaling Pathway Is Essential for the Antibody-Dependent Enhancement of Ebola Virus Infection |
|
Filoviruses: Ecology, Molecular Biology, and Evolution. |
|
Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019-nCoV |
|
The Glycoproteins of All Filovirus Species Use the Same Host Factors for Entry into Bat and Human Cells but Entry Efficiency Is Species Dependent. |
|
A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever |
|
Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors |
|
Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus |
|
Immunobiology of Ebola and Lassa virus infections |
|
Impact of polymorphisms in the DC-SIGNR neck domain on the interaction with pathogens |
|
Inactivation of RNA Viruses by Gamma Irradiation: A Study on Mitigating Factors |
|
Inhibition of Marburg virus budding by nonneutralizing antibodies to the envelope glycoprotein |
|
Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus. |
|
Kyasanur Forest Disease and Alkhurma Hemorrhagic Fever Virus-Two Neglected Zoonotic Pathogens |
|
Lack of protection against ebola virus from chloroquine in mice and hamsters |
|
Long-Range Polymerase Chain Reaction Method for Sequencing the Ebola Virus Genome From Ecological and Clinical Samples |
|
Loss of Interleukin 1 Receptor Antagonist Enhances Susceptibility to Ebola Virus Infection |
|
Mapping of conserved and species-specific antibody epitopes on the Ebola virus nucleoprotein |
|
Marburg virus pathogenesis - differences and similarities in humans and animal models |
|
The Merits of Malaria Diagnostics during an Ebola Virus Disease Outbreak |
|
Modulation of HIV and SIV neutralization sensitivity by DC-SIGN and mannose-binding lectin |
|
Modulation of virion incorporation of Ebolavirus glycoprotein: effects on attachment, cellular entry and neutralization |
|
Monoclonal Antibody Cocktail Protects Hamsters From Lethal Marburg Virus Infection |
|
Nanopore Sequencing as a Rapidly Deployable Ebola Outbreak Tool |
|
Next-generation sequencing reveals a controlled immune response to Zaire Ebola virus challenge in cynomolgus macaques immunized with vesicular stomatitis virus expressing Zaire Ebola virus glycoprotein (VSVΔG/EBOVgp). |
|
A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment |
|
Novel mutations in Marburg virus glycoprotein associated with viral evasion from antibody mediated immune pressure |
|
Novel neutralizing monoclonal antibodies protect rodents against lethal filovirus challenges |
|
Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques |
|
Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model |
|
Plasmodium Parasitemia Associated With Increased Survival in Ebola Virus-Infected Patients |
|
Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever |
|
Proteolytic activation of the 1918 influenza virus hemagglutinin |
|
Recently emerged swine influenza A virus (H2N3) causes severe pneumonia in Cynomolgus macaques |
|
Replication-deficient ebolavirus as a vaccine candidate |
|
Rhabdovirus-based vaccine platforms against henipaviruses |
|
The role of the alternative coreceptor GPR15 in SIV tropism for human cells |
|
S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients |
|
Safety of recombinant VSV-Ebola virus vaccine vector in pigs |
|
The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR. |
|
A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo |
|
Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins |
|
Single-dose VSV-based vaccine protects cynomolgus macaques from disease after Taï Forest virus infection |
|
Single-Nucleotide Polymorphisms in Human NPC1 Influence Filovirus Entry Into Cells |
|
Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus-Based Filovirus Vaccines |
|
Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor |
|
Suspected Exposure to Filoviruses Among People Contacting Wildlife in Southwestern Uganda |
|
Transcriptomic analysis reveals a previously unknown role for CD8+ T-cells in rVSV-EBOV mediated protection |
|
An updated Ebola vaccine: immunogenic, but will it protect? |
|
Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus |
|
تقييم وظيفي لدخول الخلية واستخدام المستقبلات لفيروسات النسب B-coronavirus ، بما في ذلك 2019-nCoV |
|
フィロウイルス:生態学、分子生物学および進化 |
|